Literature DB >> 2783781

Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.

C A Olson1, L C Williams, E McLaughlin-Taylor, M McMillan.   

Abstract

A major role that cytotoxic T lymphocytes (CTLs) play in the immune response is the specific destruction of viral-infected cells and tissue from foreign grafts. Class I molecules encoded within the major histocompatibility complex are the target structures for these CTLs. Recently, viral-restricted CTLs have been shown to recognize viral peptides in association with class I molecules, while several studies with cloned alloreactive CTLs have indicated that these T cells can recognize class I-derived peptides in association with class I molecules. Together, these observations suggest that peptide binding is an important function of class I molecules. In this paper, we show that the recognition of a particular class I molecule by a bulk population of alloreactive CTLs can be altered by incubating with it a peptide derived from another class I molecule. Specifically, we used the hybrid D/Ldm1 molecule as a target structure together with the peptide Ld61-85, and we have shown that their associative recognition by Ld-specific CTLs depends on sequence and configuration of the peptide and is specific for Ld using a cold-target inhibition assay. Our results are discussed in light of three possible models for the target structure(s) that can be recognized by alloreactive CTLs and in terms of the role peptides may play during allorecognition.

Mesh:

Substances:

Year:  1989        PMID: 2783781      PMCID: PMC286615          DOI: 10.1073/pnas.86.3.1031

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

Review 2.  The basis for the immunoregulatory role of macrophages and other accessory cells.

Authors:  E R Unanue; P M Allen
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

3.  Working principles in the immune system implied by the "peptidic self" model.

Authors:  P Kourilsky; G Chaouat; C Rabourdin-Combe; J M Claverie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.

Authors:  J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

5.  Tests of the helix dipole model for stabilization of alpha-helices.

Authors:  K R Shoemaker; P S Kim; E J York; J M Stewart; R L Baldwin
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

6.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Cytotoxic T lymphocytes recognize determinants on the BALB/c-H-2Ld molecule controlled by alpha 1 and alpha 2 but not alpha 3 external domains.

Authors:  I Stroynowski; A Orn; R S Goodenow; M McMillan; J Forman; P R Brayton; J Frelinger; L Hood
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.

Authors:  D Koeller; R Lieberman; J Miyazaki; E Appella; K Ozato; D W Mann; J Forman
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

9.  On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.

Authors:  T J Braciale; V L Braciale; M Winkler; I Stroynowski; L Hood; J Sambrook; M J Gething
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

10.  Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.

Authors:  J Bastin; J Rothbard; J Davey; I Jones; A Townsend
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  10 in total

1.  RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action.

Authors:  M C Cuturi; F Christoph; J Woo; S Iyer; S Brouard; J M Heslan; P Pignon; J P Soulillou; R Buelow
Journal:  Mol Med       Date:  1999-12       Impact factor: 6.354

Review 2.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

3.  Transfection into mouse L cells of genes encoding two serologically and functionally distinct bovine class I MHC molecules from a MHC-homozygous animal: evidence for a second class I locus in cattle.

Authors:  P G Toye; N D MacHugh; A M Bensaid; S Alberti; A J Teale; W I Morrison
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

Review 4.  Human autologous tumor-specific T cells in malignant melanoma.

Authors:  C D Platsoucas
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

5.  Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen.

Authors:  B Arnold; M Messerle; L Jatsch; G Küblbeck; U Koszinowski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.

Authors:  M H Sayegh; S J Khoury; W W Hancock; H L Weiner; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  On the nature of peptides involved in T cell alloreactivity.

Authors:  O Rötzschke; K Falk; S Faath; H G Rammensee
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

8.  Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.

Authors:  G Benichou; P A Takizawa; P T Ho; C C Killion; C A Olson; M McMillan; E E Sercarz
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

9.  MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation.

Authors:  E F Rosloniec; L J Vitez; S Buus; J H Freed
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.

Authors:  G Benichou; P A Takizawa; C A Olson; M McMillan; E E Sercarz
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.